You are required to be logged in to access the full website
Click here if you have forgotten your username or password
21 October 2026 - Biopharmaceutical oncology company Summit Therapeutics Inc (NASDAQ:SMMT) said on Wednesday that it has partnered with the ECOG-ACRIN Cancer Research Group to evaluate ivonescimab in a registration-enabling Phase II/III clinical tria...
21 October 2026 - RxMP Therapeutics Inc, a late pre-clinical stage therapeutics company developing novel therapies for the rapid control of hemorrhage and excessive bleeding, announced on Tuesday that it has been awarded up to USD10.7m from the US De...
21 October 2026 - Brain health supplement company TNutra announced on Tuesday the NeuraLegend system, a three-part daily brain health regimen anchored by NeuraLegend AM, which features 500 mg of Cognizin Citicoline, a patented, clinically studied cit...
21 October 2026 - Biotech company Atrium Therapeutics Inc (Nasdaq:RNA) announced on Tuesday that it has awarded inducement grants to one non-executive individual newly hired by the company, under its 2026 Employment Inducement Incentive Award Plan.Th...
20 October 2026 - American pharmaceutical company AbbVie (NYSE: ABBV) on Tuesday said Health Canada has approved SKYRIZI (risankizumab) for patients aged six to under 18 with moderate to severe plaque psoriasis who are candidates for systemic therapy...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe